Form: F-1

Registration statement for certain foreign private issuers

June 17, 2025

Exhibit 107

 

Calculation of Filing Fee Table

 

Form F-1

(Form Type)

 

CollPlant Biotechnologies Ltd.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

Security
Type
  Security
Class Title
  Fee
Calculation
Rule
  Amount
Registered(1)
    Proposed
Maximum Offering
Price Per
Share(4)
    Maximum
Aggregate
Offering Price
    Fee Rate     Amount of
Registration
Fee
 
Equity   Ordinary shares,
par value NIS 1.50 per share
  457(c)     1,272,002  (2)   $ 1.42  (3)   $ 1,806,242.84     $ 0.0001531     $ 276.54  
Total Offering Amount     1,272,002             $ 1,806,242.84             $ 276.54  
Total Fees Previously Paid                                      
Total Fee Offsets                                      
Net Fee Due                                   $ 276.54  

 

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the Registrant is also registering hereunder an indeterminate number of additional ordinary shares that shall be issuable pursuant to Rule 416 to prevent dilution resulting from stock splits, stock dividends or similar transactions.

 

(2) Consists of an aggregate of 1,272,002 of the Registrant’s ordinary shares, par value NIS 1.50 per share, issuable upon the exercise of warrants. All 1,272,002 ordinary shares are to be offered for resale by the selling shareholders named in the prospectus contained in this Registration Statement on Form F-1.

 

(3) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act and based upon the average of the high and low sale prices of the Registrant’s ordinary shares on the Nasdaq Capital Market on June 13, 2025.

 

(4) The Registrant will not receive any proceeds from the sale of its ordinary shares by the selling shareholder.